What to Know About a State-of-the-Art Approach to GIST Treatment

What to Know About a State-of-the-Art Approach to GIST Treatment

What to Know About a State-of-the-Art Approach to GIST Treatment
RestartResume
Ronald DeMatteo, MD, of Penn Medicine talks about diagnosis, treatment and research for the rare Gastrointestinal Stromal Tumor (GIST).
  • Overview

    A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan.

    Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Facebook Comments

NEW FEATURES:

Register

Join the Global Oncology Academy of learners.
Registration is free and easy.

Register Now